Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 3 | Jun 12, 2012 | clinicaltrials |
| NCT00312975 | Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | AstraZenecaINDUSTRY | 5 | Jun 7, 2012 | clinicaltrials |
| NCT00745875 | ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 5 | Jun 6, 2012 | clinicaltrials |
| NCT00088556 | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 100 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00330746 | CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer(CALC-1) | completed | Phase 2 | 100 | National Cancer Institute, NaplesOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00251446 | A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC | completed | Phase 2 | 69 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00098254 | BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00268970 | Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 30, 2012 | clinicaltrials |
| NCT01581346 | Exercise Study in Patients With Lung Cancer(POSITIVE) | completed | Phase 2 | 40 | German Cancer Research CenterOTHER | 1 | Apr 20, 2012 | clinicaltrials |
| NCT00652340 | APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer(TP2001-201) | completed | Phase 2 | 120 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 9, 2012 | clinicaltrials |
| NCT00698516 | Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer | completed | Phase 2 | 50 | GlaxoSmithKlineINDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00442754 | Dendritic Cells in Lung Cancer | completed | Phase 2 | 50 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00517595 | Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00816868 | A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung | completed | Phase 2 | 62 | Sun Yat-sen UniversityOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00034957 | Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT01270386 | A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | completed | Phase 2 | 136 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 10, 2012 | clinicaltrials |
| NCT00138658 | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 85 | Achieve Life SciencesINDUSTRY | 2 | Feb 6, 2012 | clinicaltrials |
| NCT00408226 | Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01083589 | Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT00606021 | A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Eli Lilly and CompanyINDUSTRY | 3 | Dec 26, 2011 | clinicaltrials |
| NCT01494558 | Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 0 | Dec 19, 2011 | clinicaltrials |
| NCT01222312 | Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel(Taxelox) | completed | Phase 2 | 88 | Krankenhaus NordwestOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT00051571 | Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma | completed | Phase 2 | 60 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00086333 | FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma | completed | Phase 2 | 30 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00191308 | Molecular Profiling in Lung Cancer Patients | completed | Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00072618 | Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients | completed | Phase 1 / Phase 2 | 52 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00356122 | Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 53 | SanofiINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00516022 | Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.(Iscador) | completed | Phase 2 | 79 | Rambam Health Care CampusOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00749346 | NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 42 | NovoCure Ltd.INDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 120 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00881296 | Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer(GEEP) | completed | Phase 2 | 60 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00115518 | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 30 | Heidelberg UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00040638 | Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00047801 | Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 28 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00077883 | TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 50 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 126 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01282450 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00293085 | An Open, Randomized, Multicentre, Phase II Pilot Study | completed | Phase 2 | 37 | Central European Cooperative Oncology GroupOTHER | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00531401 | Study of Salirasib to Treat Non-Small Cell Lung Cancer | completed | Phase 2 | 71 | Concordia Pharmaceuticals, IncINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC | completed | Phase 2 | 121 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT00687817 | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 49 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00372775 | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases | completed | Phase 2 | 66 | PfizerINDUSTRY | 4 | Feb 24, 2011 | clinicaltrials |
| NCT00819728 | Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 35 | SanofiINDUSTRY | 1 | Jan 11, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jun 12, 2012source: clinicaltrials